Harvard's TxGNN repurposes existing drugs for 17,000 rare diseases
Harvard Medical School researchers just launched TxGNN, the first AI model specifically built to repurpose existing medicines for rare and untreated conditions. It evaluated nearly 8,000 drugs across 17,080 diseases, beating rival models by roughly 50% while explaining its clinical reasoning. The tool is free for clinicians.